TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases

• मुख्य लेखकों: Marina Luchner (लेखक), Sören Reinke (लेखक), Anita Milicic (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2021-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to being based on subunit components. Since this diminishes immunogenicity, vaccine adjuvants that enhance the immune response to purified antigens are critically needed. Further advantages of adjuvants include dos...